The accompanying consolidated financial statements, in the opinion of management, include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the results for the interim periods presented.
For further information, refer to the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2017.
The Company’s results for the three and six-month periods ended March 31, 2018 are not necessarily indicative of the results for the entire 2018 fiscal year.
On March 14, 2018, the Company acquired the assets of Manta Test Systems Inc.
Since the date of acquisition, the operating results for Manta have been included as a product line of Doble within the Company’s USG segment.
Based on the preliminary purchase price allocation, the Company recorded approximately $0.4 million of accounts receivable, $1.1 million of inventory, $0.2 million of property, plant and equipment, $0.4 million of accounts payable and accrued expenses, $3.5 million of goodwill, $1.2 million of tradenames and $3.6 million of amortizable intangible assets consisting of customer relationships with a weighted average life of 13 years.
The Company provides compensation benefits to certain key employees under several share-based plans providing for performance-accelerated restricted shares (restricted shares), and to non-employee directors under a non-employee directors compensation plan.
Compensation expense related to the restricted share awards was $1.0 million and $2.1 million for the three and six-month periods ended March 31, 2018, respectively, and $1.2 million and $2.4 million for the corresponding periods of 2017.References to the second quarters of 2018 and 2017 represent the three-month periods ended March 31, 2018 and 2017, respectively.
In the second quarter of 2018, sales, net earnings and diluted earnings per share were $174.8 million, $10.0 million and $0.38 per share, respectively, compared to $161.2 million, $11.2 million and $0.43 per share, respectively, in the second quarter of 2017.
Net sales increased $13.6 million, or 8.4%, to $174.8 million in the second quarter of 2018 from $161.2 million in the second quarter of 2017.
Net sales increased $40.8 million, or 13.2%, to $348.3 million in the first six months of 2018 from $307.5 million in the first six months of 2017.
The increase in net sales in the second quarter of 2018 as compared to the second quarter of 2017 was due to a $14.0 million increase in the USG segment, a $2.4 million increase in the Test segment and a $0.3 million increase in the Technical Packaging segment, partially offset by a $3.1 million decrease in the Filtration segment.
The increase in net sales in the first six months of 2018 as compared to the corresponding prior year period was due to a $34.3 million increase in the USG segment, a $6.2 million increase in the Test segment and a $2.2 million increase in the Technical Packaging segment, partially offset by a $1.9 million decrease in the Filtration segment.
In the second quarter of 2018, net sales of $40.8 million were $2.4 million, or 6.3%, higher than the $38.4 million recorded in the second quarter of 2017.
Net sales increased $6.1 million, or 8.4%, to $78.3 million in the first six months of 2018 from $72.2 million in the first six months of 2017.
Net sales increased $14.0 million, or 42.8%, to $46.7 million in the second quarter of 2018 from $32.7 million in the second quarter of 2017.
Net sales increased $34.3 million, or 50.3%, to $102.5 million in the first six months of 2018 from $68.2 million in the first six months of 2017.
The increase in the second quarter of 2018 compared to the second quarter of 2017 was mainly due to the sales contributions from the NRG, Morgan Schaffer and Vanguard Instruments (Vanguard) acquisitions.